TCIM
NEO icon

TIAA CREF Investment Management’s NeoGenomics NEO Stock Holding History

TIAA CREF Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$15.1M Buy
740,107
+48,356
+7% +$840K 0.01% 832
2018
Q4 		$8.72M Buy
691,751
+154,729
+29% +$2.31M 0.01% 1019
2018
Q3 		$8.24M Buy
537,022
+287,055
+115% +$3.97M 0.01% 1228
2018
Q2 		$3.28M Buy
249,967
+118,176
+90% +$1.3M ﹤0.01% 1898
2018
Q1 		$1.07M Sell
131,791
-6,132
-4% -$49.7K ﹤0.01% 2402
2017
Q4 		$1.22M Sell
137,923
-8,565
-6% -$79K ﹤0.01% 2368
2017
Q3 		$1.63M Sell
146,488
-2,732
-2% -$26.6K ﹤0.01% 2280
2017
Q2 		$1.34M Buy
149,220
+581
+0.4% +$4.61K ﹤0.01% 2406
2017
Q1 		$1.17M Sell
148,639
-3,169
-2% -$25.8K ﹤0.01% 2429
2016
Q4 		$1.3M Sell
151,808
-6,929
-4% -$59.4K ﹤0.01% 2405
2016
Q3 		$1.3M Sell
158,737
-4,526
-3% -$38K ﹤0.01% 2402
2016
Q2 		$1.31M Sell
163,263
-4,023
-2% -$32.2K ﹤0.01% 2380
2016
Q1 		$1.13M Sell
167,286
-24,358
-13% -$160K ﹤0.01% 2409
2015
Q4 		$1.51M Sell
191,644
-6,980
-4% -$51.1K ﹤0.01% 2332
2015
Q3 		$1.14M Buy
198,624
+58,372
+42% +$361K ﹤0.01% 2494
2015
Q2 		$759K Buy
+140,252
New +$723K ﹤0.01% 2831
2014
Q3 		– Sell
-428
Closed -$1K – 3131
2014
Q2 		$1K Sell
428
-133,686
-100% -$444K ﹤0.01% 3110
2014
Q1 		$465K Hold
134,114
– – ﹤0.01% 2962
2013
Q4 		$485K Hold
134,114
– – ﹤0.01% 2967
2013
Q3 		$402K Buy
134,114
+2,955
+2% +$8.33K ﹤0.01% 2984
2013
Q2 		$522K Buy
+131,159
New +$500K ﹤0.01% 2924

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TIAA CREF Investment Management's NEO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its NeoGenomics (NEO) stake by 7% in Q1 2019, buying an estimated $840K and bringing the position to 740,107 shares worth $15.1M. The position accounts for 0.01% of the portfolio, ranked #832.

TIAA CREF Investment Management first reported a position in NEO in Q2 2013 and has held it in 21 quarters since. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • TIAA CREF Investment Management held 740,107 shares of NeoGenomics worth $15.1M as of Q1 2019.
  • TIAA CREF Investment Management bought 48,356 NeoGenomics shares in Q1 2019, an estimated $840K.
  • NeoGenomics made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #832 holding.
  • TIAA CREF Investment Management first reported a position in NeoGenomics in Q2 2013 and has held it in 21 quarters since.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.